Medical News

RSS
Eyes turn to Lieberman, Reid, Snowe as most crucial health reform players

Eyes turn to Lieberman, Reid, Snowe as most crucial health reform players

Brookstone Pharmaceuticals changes its name to Acella Pharmaceuticals

Brookstone Pharmaceuticals changes its name to Acella Pharmaceuticals

Third-quarter fiscal 2009 results announced by GeneLink

Third-quarter fiscal 2009 results announced by GeneLink

New mobile yoga class app for iPhone and iPod Touch iPractice 2.0 released

New mobile yoga class app for iPhone and iPod Touch iPractice 2.0 released

Electronic health records not yet making impact, patients turn to web for advice

Electronic health records not yet making impact, patients turn to web for advice

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

4SC raises funds for further development of its current product pipeline

4SC raises funds for further development of its current product pipeline

Health lobbying ranges from below the radar to high profile

Health lobbying ranges from below the radar to high profile

Drug makers hike prices, lobby hard as reform efforts progress

Drug makers hike prices, lobby hard as reform efforts progress

Onyx Pharmaceuticals acquires Proteolix

Onyx Pharmaceuticals acquires Proteolix

Coming this week: New law to prevent discrimination based on genes

Coming this week: New law to prevent discrimination based on genes

Insuring immigrants a sticking point between House, Senate health reform bills

Insuring immigrants a sticking point between House, Senate health reform bills

Both sides puzzle over abortion amendment in House health bill

Both sides puzzle over abortion amendment in House health bill

Today's opinions and editorials

Today's opinions and editorials

2009 report: False Medicare claims cost government more than $47 billion

2009 report: False Medicare claims cost government more than $47 billion

Cord Blood reports its 10Q filing with the U.S. SEC for the three and nine-month period ended September 30, 2009

Cord Blood reports its 10Q filing with the U.S. SEC for the three and nine-month period ended September 30, 2009

Gentium to present Defibrotide trial data at the ASH meeting

Gentium to present Defibrotide trial data at the ASH meeting

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Eclipsys’ Sunrise Patient Flow solution activated successfully at Singapore General Hospital

Eclipsys’ Sunrise Patient Flow solution activated successfully at Singapore General Hospital

Erbitux recognized as one of the major clinical cancer advances of 2009

Erbitux recognized as one of the major clinical cancer advances of 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.